project-idea
This study created the first humanized ossicle model that faithfully reproduces myelofibrosis features including reticulin fibrosis and osteosclerosis, and identified SPP1 as a new therapeutic target — highlighting both a model gap and a drug target gap that a structured resource could help address.
project-idea
BRCA1/2 mutations in lung adenocarcinoma predict better responses to immune checkpoint blockade despite worse overall prognosis — creating a paradox that clinicians need tools to navigate when making immunotherapy decisions for NSCLC patients.
project-idea
Transformed breast cells use physical nanotube connections to transmit BMP signaling to normal neighbors, actively spreading a preneoplastic state — meaning early cancer initiation may be a contagious process, not just isolated mutations.
project-idea
When PI3K is blocked in AML cells, the cancer compensates by upregulating EZH1 — an escape route that can be closed by combining PI3K inhibitors with EZH1/2 dual inhibitors. This research makes a compelling case for systematically mapping known resistance bypass routes and their combination therapy…
colorectal-cancer
A large analysis of DNA from over 9,000 patients found that colorectal tumors consistently host distinct microbial communities—a finding that was specific to colorectal cancer and not observed in other cancer types analyzed. This 'microbial fingerprint' could have diagnostic and therapeutic…
brain-cancer
Canadian researchers discovered that specific brain support cells can send signals that strengthen glioblastoma cancer cells and help tumors grow. When researchers blocked this cellular communication pathway, tumor growth slowed dramatically in preclinical experiments.
other-cancer
BET inhibitors (targeting BRD2 and BRD4 proteins) have shown promise in cancer research but frequently disappointing results in clinical trials. This study reveals that BRD2 and BRD4 have distinct, non-overlapping functions. Current BET inhibitors that block both simultaneously may disrupt cellular…
other-cancer
Zeaxanthin, a carotenoid nutrient found in leafy greens and egg yolks and commonly taken for eye health, has been found to strengthen T cells and enhance the impact of cancer immunotherapy treatments in a preclinical study. The mechanism involves improved T cell metabolic fitness and anti-tumor…
breast-cancer
Researchers are launching a new project to study how aggressive breast cancers interact with and suppress the immune system. The project will use real patient samples to study tumor evolution and identify new biomarkers that reveal how the cancer progresses. The ultimate goal is to translate…
breast-cancer
Ductal carcinoma in situ (DCIS) is a pre-invasive breast condition often treated with surgery, but its natural history and optimal management are debated. This study found that women who chose active surveillance for DCIS had ipsilateral invasive breast cancer survival rates similar to those who…
breast-cancer
This study with 10-year follow-up confirmed that radiotherapy tailored to pathological nodal response (rather than standardized protocols) in breast cancer achieves very low locoregional recurrence rates—less than 3% of patients experienced recurrence, most within the first 5 years.
lung-cancer
Low-dose CT lung cancer screening frequently detects incidental findings beyond lung nodules. This study found that significant incidental findings on screening CT were associated with an increased risk of being diagnosed with a non-lung cancer (extrapulmonary cancer) within the following year.
